BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2467367)

  • 1. On the production of immunoglobulins in the central nervous system: an involvement of B cell stimulatory factor 2/interleukin 6 produced intrathecally?
    Fontana A; Frei K; Malipiero UV; Leist TP; Schwab M
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):38-9. PubMed ID: 2467367
    [No Abstract]   [Full Text] [Related]  

  • 2. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases.
    Frei K; Malipiero UV; Leist TP; Zinkernagel RM; Schwab ME; Fontana A
    Eur J Immunol; 1989 Apr; 19(4):689-94. PubMed ID: 2543584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in interleukin-2-deficient mice.
    Kündig TM; Schorle H; Bachmann MF; Hengartner H; Zinkernagel RM; Horak I
    Science; 1993 Nov; 262(5136):1059-61. PubMed ID: 8235625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immunological response in infections of the central nervous system.
    McFarland HF
    Adv Neurol; 1974; 6():19-25. PubMed ID: 4548628
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
    Molina TJ; Bachmann MF; Kündig TM; Zinkernagel RM; Mak TW
    J Immunol; 1993 Jul; 151(2):699-706. PubMed ID: 8393038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-mediated immunopathology in viral infections.
    Doherty PC; Zinkernagel RM
    Transplant Rev; 1974; 19(0):89-120. PubMed ID: 4601807
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
    Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM
    Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    Stitz L; Althage A; Hengartner H; Zinkernagel R
    J Immunol; 1985 Jan; 134(1):598-602. PubMed ID: 2981094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
    Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus.
    Osiak A; Utermöhlen O; Niendorf S; Horak I; Knobeloch KP
    Mol Cell Biol; 2005 Aug; 25(15):6338-45. PubMed ID: 16024773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic choriomeningitis virus-induced ocular immunopathology.
    Silverstein AM; Ticho U; Monjan AA; Cole GA
    Mod Probl Ophthalmol; 1976; 16():208-14. PubMed ID: 1082541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of virus infections by natural killer cells. A review.
    Welsh RM
    Nat Immun Cell Growth Regul; 1986; 5(4):169-99. PubMed ID: 2430177
    [No Abstract]   [Full Text] [Related]  

  • 13. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection.
    Moskophidis D; Lehmann-Grube F
    J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients.
    Frei K; Leist TP; Meager A; Gallo P; Leppert D; Zinkernagel RM; Fontana A
    J Exp Med; 1988 Jul; 168(1):449-53. PubMed ID: 3135367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific IgD in acute viral infection of mice.
    Moskophidis D; Moskophidis M; Löhler J
    J Immunol; 1997 Feb; 158(3):1254-61. PubMed ID: 9013967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell responses and immune memory.
    Slifka MK; Ahmed R
    Dev Biol Stand; 1998; 95():105-15. PubMed ID: 9855420
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of the immunoglobulin eluted from the glomeruli of mice chronically infected with lymphocytic choriomeningitis virus.
    Klein B; Hill C; Hoffsten PE
    J Immunol; 1977 Aug; 119(2):707-13. PubMed ID: 889613
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.